Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651 1657 1682
This examiner grants 43% of resolved cases
Dennis Ignatius Armato Jr. handles cases in Tech Center 1600 and Art Unit 1651. With 21 resolved cases, the examiner has an allowance rate of 42.9 percent. This 42.9 percent rate indicates the frequency of granted patents among the 21 resolved cases. Practitioners can use these figures to evaluate the prosecution environment and the likelihood of success in this specific unit.
The interview lift is 80.0 percent, which is a statistic that shows the change in allowance probability following an interview. This 80.0 percent lift is a notable metric for developing a strategy. The median days to allowance is 1250, providing a benchmark for the time required to reach a grant. This 1250-day median is a key data point for managing expectations. These figures from Tech Center 1600 and Art Unit 1651 serve as the basis for understanding the examiner's historical performance and the duration of the prosecution cycle.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18508825 | GENETICALLY ENCODED SYNTHETIC REACTION-DIFFUSION SYSTEM THAT CAN GENERATE PROGRAMMABLE OSCILLATIONS, PATTERNS, AND SPATIOTEMPORAL SIGNALING CIRCUITS IN MAMMALIAN CELLS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18558026 | CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE | Final Rejection | EMORY UNIVERSITY |
| 18813058 | ASPERGILLUS SP. L14-OE::LAEA2 AND APPLICATION THEREOF IN PRODUCING CYCLIC TRIPEPTIDES | Non-Final OA | Zhejiang University of Technology |
| 18561123 | METHODS OF PRODUCTING HMO BLEND PROFILES WITH LNFP-1 AND 2'-FL AS THE PREDOMINANT COMPOUNDS | Final Rejection | DSM IP Assets B.V. |
| 17283007 | REPORTER CONSTRUCTS FOR NANOPORE-BASED DETECTION OF BIOLOGICAL ACTIVITY | Final Rejection | UNIVERSITY OF WASHINGTON |
| 18022004 | MODIFIED SERINE PROTEASE PROPROTEINS | Non-Final OA | The University of Chicago |
| 18843824 | Materials and Methods for Iron Capture and Greenhouse Gas Reduction | Non-Final OA | Locus Solutions IPCo, LLC |
| 18026678 | METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS | Non-Final OA | AMGEN INC. |
| 17782279 | ENZYME COMPOSITIONS AND USES THEREOF | Final Rejection | Novozymes A/S |
| 18026421 | NOVEL ADENO-ASSOCIATED VIRAL (AAV) VECTORS TO TREAT HEREDITARY METHYLMALONIC ACIDEMIA (MMA) CAUSED BY METHYLMALONYL-COA MUTASE (MMUT) DEFICIENCY | Final Rejection | The United States of America,as represented by the Secretary,Department of Health and Human Services |
| 18746141 | NOMADIC BACTERIA AND USES THEREOF | Non-Final OA | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
| 18543604 | METHODS FOR INCREASING MENTAL WELL-BEING AND/OR HAPPINESS | Final Rejection | Fonterra Co-Operative Group Limited |
| 17775101 | SYNTHETIC ALPHA-SECRETASE AND USE THEREOF | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 18275331 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES | Final Rejection | UNIVERSITÉ DE MONTPELLIER |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy